// App-Quantinova.ai

1805 : Throly Score Successfully Classifies Hodgkin Lymphoma Patients at Risk of Thromboembolic Complication

Researchers

Presenter

  • Darko Antic

Principal Investigators

  • Vladimir Otasevic

  • Sven Borchmann

  • Horst Muller

  • Vojin Vukovic

  • Vladislava Djurasinovic

  • Kristina Tomic

  • Biljana Mihaljevic

  • Grigoris Gerotziafas

  • Andreas Engert

  • Jawed Fareed

Medical Centers

  • Clinic of Nephrology, Clinical Center of Serbia, Belgrade, Serbia

  • Serbian Lymphoma Group, Belgrade, Serbia

  • Medical School, University of Belgrade, Belgrade, Serbia

  • Department I of Internal Medicine and Center of Integrated Oncology Aachen, Bonn, Cologne, Duesseldorf, University of Cologne, Cologne, Germany

  • University Hospital Cologne, German Hodgkin Study Group GHSG, Cologne, Germany

  • Sorbonne Universities, Faculty of Medicine, Cancer, Haemostasis and Angiogenesis Research Group, INSERM U938, Institut Universitaire de Cancérologie, Paris, France

  • Service d'hematologie biologique Hôpital Tenon APHP, Thrombosis center, Paris, France

  • Loyola University Medical Center, Maywood, IL

Locations

  • Serbia

  • Germany

  • France

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Hodgkin's Lymphoma

  • Venous thrombosis

  • Lymphomas

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A